Loading
Latest filing published 12 Jan 2010 for Osteologix, Inc., €698k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Nordic Biotech General Partner ApS is a declared insider of Osteologix, Inc., with filings sourced from SEC (Form 4). Between 7 January 2010 and 11 June 2010, the trades on record add up to 3 filings.
The open-market record is one-sided, with 3 purchases worth €1.4M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €619k.
The latest filing, published on 11 June 2010, reports an open-market purchase of €619k in Osteologix, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration